scholarly article | Q13442814 |
P356 | DOI | 10.3892/IJMM_00000530 |
P953 | full work available at URL | https://www.spandidos-publications.com/10.3892/ijmm_00000530/download |
P698 | PubMed publication ID | 21042775 |
P2093 | author name string | Yu Huang | |
Xingsheng Yang | |||
Zhumei Cui | |||
Fuling Wang | |||
Yanhui Lou | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell migration | Q189092 |
P304 | page(s) | 819-827 | |
P577 | publication date | 2010-12-01 | |
P1433 | published in | International Journal of Molecular Medicine | Q6051492 |
P1476 | title | MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein | |
P478 | volume | 26 |
Q50475646 | A syntenic locus on buffalo chromosome 20: novel genomic hotspot for miRNAs involved in follicular-luteal transition. |
Q38407369 | Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer |
Q34991261 | Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis |
Q39239168 | Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation |
Q36238604 | Changes of Ovarian microRNA Profile in Long-Living Ames Dwarf Mice during Aging |
Q36517492 | Current status and implications of microRNAs in ovarian cancer diagnosis and therapy |
Q52665461 | Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer. |
Q34305434 | Discovery of prognostic factors for diagnosis and treatment of epithelial-derived ovarian cancer from laying hens. |
Q26851604 | Diverse mechanisms of AKT pathway activation in human malignancy |
Q39063867 | Down-regulation of PTEN expression modulated by dysregulated miR-21 contributes to the progression of esophageal cancer |
Q33615837 | Epigenetic control of autophagy by microRNAs in ovarian cancer |
Q42844079 | Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer |
Q90611608 | Evaluation of miR-22 and miR-21 as diagnostic biomarkers in patients with epithelial ovarian cancer |
Q93369514 | Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer |
Q26797287 | Focus on PTEN Regulation |
Q35010133 | Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro |
Q35698913 | From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma |
Q50059680 | Genetic ablation of Rbm38 promotes lymphomagenesis in the context of mutant p53 by downregulating PTEN. |
Q36112656 | High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma |
Q51576068 | Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer. |
Q46249375 | Identification of Reference Genes for Analysis of microRNA Expression Patterns in Equine Chorioallantoic Membrane and Serum |
Q38468383 | Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis |
Q21198790 | Involvement of autophagy in ovarian cancer: a working hypothesis |
Q47144631 | Isoflurane promotes glucose metabolism through up-regulation of miR-21 and suppresses mitochondrial oxidative phosphorylation in ovarian cancer cells |
Q93048655 | Loss of PTEN in Fallopian Tube Epithelium Results in Multicellular Tumor Spheroid Formation and Metastasis to the Ovary |
Q38017596 | MicroRNA control of epithelial-mesenchymal transition and metastasis. |
Q34991006 | MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a. |
Q35690705 | MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia |
Q33922687 | MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers |
Q55418376 | MicroRNA-19b promotes the migration and invasion of ovarian cancer cells by inhibiting the PTEN/AKT signaling pathway. |
Q39283860 | MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. |
Q37372163 | MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro |
Q34278292 | MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis |
Q47124790 | MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK. |
Q26822743 | MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer |
Q39333266 | MicroRNAs in gynecological cancers: Small molecules with big implications |
Q26853284 | MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT) |
Q39001832 | Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells |
Q37335617 | Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets |
Q36642134 | Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer |
Q34238901 | Prognostic significance of miR-205 in endometrial cancer |
Q36675556 | Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis |
Q29248612 | Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases |
Q38191102 | Regulation of microRNAs in cancer metastasis. |
Q39458426 | Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression |
Q37729033 | Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer |
Q38379454 | Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression |
Q52562510 | Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project. |
Q34447755 | Serum microRNA-155 as a potential biomarker to track disease in breast cancer |
Q42876911 | Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis |
Q34408233 | Serum microRNAs as non-invasive biomarkers for cancer |
Q33862343 | Set9, NF-κB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells |
Q26829982 | Small molecule compounds targeting miRNAs for cancer therapy |
Q90469311 | Targeting of CD38 by the tumor suppressor miR-26a serves as a novel potential therapeutic agent in multiple myeloma |
Q92404854 | The Inducible microRNA-21 Negatively Modulates the Inflammatory Response in Teleost Fish via Targeting IRAK4 |
Q36820568 | The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer |
Q39029645 | The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer |
Q26777880 | Therapies targeting cancer stem cells: Current trends and future challenges |
Q28539122 | Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway |
Q33941190 | miR-16 and miR-21 expression in the placenta is associated with fetal growth |
Q41770486 | miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer |
Q38739495 | miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development. |
Q36464776 | miR-21 expression predicts prognosis in diffuse large B-cell lymphoma |
Q41143550 | miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN. |
Q92339469 | miRNA-21 inhibition suppresses the human epithelial ovarian cancer by targeting PTEN signal pathway |
Q38092617 | miRNA-Based Therapeutic Strategies |
Q38667018 | microRNA and Ovarian Cancer |
Q36084306 | microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. |
Search more.